NSCLC
These data suggest that RH1 may be an effective NQO1-directed antitumor agent for the therapy of tumors with elevated NQO1 activity, such as NSCLC.
These data suggest that RH1 may be an effective <span class="gene" id="9865924-10-48-52">NQO1</span>-directed antitumor agent for the therapy of tumors with elevated <span class="gene" id="9865924-10-118-122">NQO1</span> activity, such as <span class="disease" id="9865924-10-141-146">NSCLC</span>.